AR037214A1 - Secuencias de proteinas nucleares de hcv - Google Patents

Secuencias de proteinas nucleares de hcv

Info

Publication number
AR037214A1
AR037214A1 ARP020104218A ARP020104218A AR037214A1 AR 037214 A1 AR037214 A1 AR 037214A1 AR P020104218 A ARP020104218 A AR P020104218A AR P020104218 A ARP020104218 A AR P020104218A AR 037214 A1 AR037214 A1 AR 037214A1
Authority
AR
Argentina
Prior art keywords
hcv
modified
protein
antibodies
nuclear
Prior art date
Application number
ARP020104218A
Other languages
English (en)
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of AR037214A1 publication Critical patent/AR037214A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/20Analysis of motion
    • G06T7/246Analysis of motion using feature-based methods, e.g. the tracking of corners or segments
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/20Analysis of motion
    • G06T7/277Analysis of motion involving stochastic approaches, e.g. using Kalman filters

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Multimedia (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente describe péptidos y proteínas recombinantes que contienen la secuencia de la proteína nuclear del virus Hepatitis C en la cual uno o más aminoácidos han sido modificados o suprimidos para eliminar la capacidad de estas proteínas para unirse a anticuerpos monoclonales murinos anti-HCV específicos. Las deleciones y modificaciones han sido disenadas a fin de mantener la aptitud de esta proteína para ser utilizada en los inmunoensayos utilizados para la detección de anticuerpos anti-HCV en individuos infectados por HCV. Reivindicación 1: Un kit para la detección del HCV que comprende A) una fase sólida revestida con proteína nuclear modificada de HCV, proteína no nuclear del HCV y por lo menos un anticuerpo monoclonal antinuclear de HCV y B) un anticuerpo monoclonal antinuclear de HCV conjugado, donde la proteína nuclear modificada de la parte A) ha sido modificada mediante la eliminación de los sitios de unión de los anticuerpos monoclonales antinucleares de la parte A) y la parte B).
ARP020104218A 2001-11-11 2002-11-05 Secuencias de proteinas nucleares de hcv AR037214A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34730301P 2001-11-11 2001-11-11
US10/268,569 US7332269B2 (en) 2001-11-11 2002-10-10 HCV core protein sequences

Publications (1)

Publication Number Publication Date
AR037214A1 true AR037214A1 (es) 2004-10-27

Family

ID=27668510

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104218A AR037214A1 (es) 2001-11-11 2002-11-05 Secuencias de proteinas nucleares de hcv

Country Status (9)

Country Link
US (1) US7332269B2 (es)
EP (1) EP1310512B1 (es)
JP (1) JP4283527B2 (es)
AR (1) AR037214A1 (es)
AT (1) ATE512977T1 (es)
BR (1) BRPI0204599B8 (es)
CA (1) CA2408174C (es)
ES (1) ES2365800T3 (es)
PT (1) PT1310512E (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101287989B (zh) * 2005-02-02 2016-04-13 菲鹏生物股份有限公司 一种丙型肝炎病毒抗体检测试剂盒及其制备方法
US8865398B2 (en) * 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1148859A (en) 1979-06-14 1983-06-28 Lacy R. Overby Simultaneous assay of two hepatitis viruses using a solid phase
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DE4112743C2 (de) 1991-04-19 2000-01-13 Dade Behring Marburg Gmbh Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
JP3516681B2 (ja) 1991-06-24 2004-04-05 カイロン コーポレイション C型肝炎ウイルス(hcv)ポリペプチド
DE69837703T2 (de) 1997-08-04 2008-01-10 Advanced Life Science Institute, Inc., Iruma Methoden zum nachweis und zur analyse von virus
BR9906660A (pt) * 1998-07-30 2000-08-29 Advanced Life Science Inst Inc Processo para medir vìrus da hepatite c
US6632601B2 (en) 2000-06-15 2003-10-14 Chiron Corporation Immunoassays for anti-HCV antibodies
AU785380B2 (en) 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US20030108563A1 (en) 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies

Also Published As

Publication number Publication date
EP1310512A3 (en) 2004-01-21
ATE512977T1 (de) 2011-07-15
EP1310512B1 (en) 2011-06-15
CA2408174A1 (en) 2003-05-11
BRPI0204599B8 (pt) 2021-07-27
JP2003279579A (ja) 2003-10-02
US20030152965A1 (en) 2003-08-14
US7332269B2 (en) 2008-02-19
CA2408174C (en) 2012-07-17
ES2365800T3 (es) 2011-10-11
BRPI0204599B1 (pt) 2018-03-06
PT1310512E (pt) 2011-08-04
EP1310512A2 (en) 2003-05-14
BR0204599A (pt) 2003-09-16
JP4283527B2 (ja) 2009-06-24

Similar Documents

Publication Publication Date Title
DE69111801D1 (de) Vakzin gegen hepatitis b.
NO934542L (no) Hepatitt C virus (HCV) polypeptider
ATE458494T1 (de) Von der telomerase abgeleitete antigene peptide
DK0450931T3 (da) Kombinationer af hepatitis C-virus (HCV)-antigener til anvendelse i immunoassays for anti-HCV-antistoffer
DK1135498T3 (da) Antistofvarianter med höjere bindingsaffinitet end forældreantistoffer
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
UY28641A1 (es) Anticuerpos
NO20051715L (no) HCV assay
AR037214A1 (es) Secuencias de proteinas nucleares de hcv
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
ATE312846T1 (de) Monoklonale antikörper gegen hepatitis b virus
TW200720656A (en) Prediction of prognosis of liver disease associated with hepatitis c virus infection
KR100310413B1 (ko) 인간의자연형lgM항체
ES2087242T3 (es) Ensayo para el virus de la anemia infecciosa equina.
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
AR037215A1 (es) Reactivos para la deteccion simultanea de anticuerpos y antigenos nucleares del hcv
ES2163964A1 (es) Peptidos derivados del extremo amino de la vp5 de orbivirus y su empleo en diagnostico y vacunas.
EA199900934A1 (ru) Применение микрочастиц, содержащих адсорбированные на них белок и антитела, для получения фармацевтической композиции для интраназального введения

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee